Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 505 (CSE: $PULL.C) (TSXV: $HITI.V) (TSX: $WEED.TO) (NASDAQ: $CGC) (TSXV: $ENW.V)
Delta, Kelowna, BC, December 9, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/120920-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/12091PULL-HITI-WEED-CGC-ENW.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few private and public company
announcements.
Pure
Extracts Technologies Corp. (CSE:
PULL), a plant-based extraction company focused on
cannabis, hemp and the rapidly emerging functional mushroom sector, announced that it
has signed a letter of intent (LOI) with The Nutraceutical Medicine Company
Inc., owner of the PURICA™ brand of full-spectrum mushroom derived wellness
products, to support Pure Extracts’ expansion into the functional mushroom
sector and to co-develop CBD-full-spectrum mushroom wellness combinations.
PURICA has a track record of more
than 20 years of bringing its customers the very best that nature has to offer;
skillfully-formulated natural and whole food products solidly-backed by
science. Based in Duncan, B.C. on Vancouver Island, PURICA is an award-winning
company whose Immune 7 formulation
has been named by Canadian retailers two years running as the gold award winner
as the best immunity product in Canada in the prestigious alive Awards (2019 and 2020).
PURICA is also a leader in educating
the public about the uses and benefits of medicinal full-spectrum mushrooms
with formulations targeting immunity and stress relief, sleep, heart health,
weight management, endurance, performance, hormonal balance and a host of other
conditions.
Pure Extracts CEO, Ben Nikolaevsky,
commented, “We are excited to be working with the experts at PURICA on
functional mushroom products and novel CBD formulations. They have an
impressive history of product development, customer retention and an unwavering
dedication to high standards.”
The marriage of full-spectrum
mushroom extracts and CBD would be a ground-breaking achievement and would
uniquely position Pure Extracts at the confluence of two very powerful trends –
the rapid adoption of CBD oil as a mainstream medicinal product and the
explosive growth of functional mushroom wellness products. With the help of
Pure Extracts’ scientific advisor, Dr. Alexander MacGregor, President of the
Toronto Institute of Pharmaceutical Technology, the Company believes that it
can expedite the formulation of this new category of wellness products with the
highest bioavailability in the market today.
High
Tide Inc.
(TSXV:
HITI) (OTCQB:
HITIF), a retail-focused cannabis corporation enhanced by
the manufacturing and distribution of smoking accessories, announced that it
has submitted an initial application to list on The Nasdaq Stock Market, and
has retained Pryor Cashman LLP as legal counsel. The Company is pursuing a
Nasdaq listing to enhance its investor profile as a part of its capital markets
initiative with the goal of enhancing shareholder value. This initiative allows
the Company to accelerate its business strategy focused on the United States,
both in attracting institutional and retail investors and M&A opportunities
within the US. The Company already earns approximately 23% of its revenue in
the US, and is seeking to expand its footprint in the US in businesses that
complement the Company's business divisions that focus on CBD and accessories,
while ensuring that it remains in compliance with all applicable laws and
regulations in the US.
"We are very excited about the
prospect of listing on Nasdaq. With our recent acquisition of Meta Growth, we
are now the largest Canadian retailer as measured by revenue. Listing on Nasdaq
would allow the Company to expand its shareholder base, enhance shareholder
value and accelerate the Company's M&A initiatives in pursuing strategic
opportunities in the US." said Raj Grover, President and Chief Executive
Officer.
In advance of an anticipated listing
on Nasdaq, High Tide will file a Registration Statement with the United States
Securities and Exchange Commission. The listing of the Company's common shares
on Nasdaq remains subject to the review and approval of the listing application
and the satisfaction of all applicable listing and regulatory requirements, as
well as effectiveness of the registration statement. The Company will continue
to maintain the listing of its Shares on the TSX Venture Exchange under the
symbol "HITI."
Canopy
Growth Corporation (TSX:
WEED) (NASDAQ:
CGC)
today
announced a series of Canadian operational changes designed to
streamline its operations and further improve margins.
Canopy Growth will cease operations
at the following sites: St. John's, Newfoundland and Labrador; Fredericton, New
Brunswick; Edmonton, Alberta; Bowmanville, Ontario; as well as its outdoor
cannabis grow operations in Saskatchewan. Approximately 220 employees have been
impacted as a result of these closures.
"As part of the end-to-end
review of our operations that we outlined during our second-quarter earnings
call, we have made the decision to close a number of our production facilities.
These actions will be an important step towards achieving our targeted
$150-$200MM of cost savings and accelerating our path to profitability. We are
confident that our remaining sites will be able to produce the quantity and
quality of cannabis required to meet current and future demand," said
David Klein, CEO, Canopy Growth. "This was a difficult decision but I
believe it is the right one. I want to thank all of the employees impacted by
this decision for their efforts in helping build Canopy Growth."
These decisions are the partial
outcome of an ongoing end-to-end review designed to improve the Company's
margins. The end-to-end review was announced during the Company's Q2 earnings
call and looks at people, process, technology, and infrastructure. The Company
expects to record estimated total pre-tax charges of approximately $350-400MM
in the third and fourth quarters of Fiscal 2021.
The production sites impacted
represent approximately 17% of the Company's enclosed Canadian footprint and
100% of its Canadian outdoor production footprint.
EnWave
Corporation (TSX-V:
ENW)
announced
today the successful research and development results of a
new terpene retention process for drying cannabis using Radiant Energy Vacuum
(“REV™”) dehydration technology.
Third-party, lab-verified results
demonstrate that EnWave’s patented REV™ technology can deliver a higher
percentage of retained terpenes, approximately 10% higher, than traditional
cannabis drying methods such as air drying or rack/room drying. The Company
offers scaleable, continuous REV™ machinery that can process up to 28 metric
tons of high-terpene, dried cannabis per year using the Terpene Max™ process,
and up to 46 metric tons of dried cannabis to be used for extraction purposes
per year.
This new process, branded as Terpene
Max™, further demonstrates the advantages of the Company’s scaleable,
proprietary vacuum-microwave drying technology for the global cannabis
industry. Terpene Max™ ensures that drying temperatures remain well below 40
degrees Celsius for the entire drying process, which takes less than two hours.
The chart accompanying this
announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6e0f4eb4-c3f4-4f77-b798-a234a3f713cc
Chart: The data in the chart above
was analyzed at an independent testing facility. The results shown represent
the average percentage of terpenes retained from three separately analyzed
samples of the same batch of dried cannabis.
The initial quantitative results
from using the new Terpene Max™ drying program on a specific low-THC cannabis
strain demonstrated an average terpene retention level of 88 percent when
compared to the fresh flower, making it materially superior to traditional air
or rack/room drying where terpene retention averages 79 percent.
The tests were conducted for the
Company by accredited, third-party testing facilities using cannabis product
dried with large-scale, continuous REV™ technology at a licensed partner’s
facilities against standard room-dried protocols. Further data, analysis and
certified results will be released in a white paper that will be published in
January 2021.
Terpenes are known to have
therapeutic effects and are foundational to aromatherapies. Industry research
shows that terpenes from cannabis work synergistically with cannabinoids to
deliver a better user experience.
EnWave believes that the Terpene Max™
process has the potential to create an ultra-premium consumer product. The
Company will be executing further trials with multiple cannabis strains in the
coming months to understand the full potential of Terpene Max™ on ultra-premium
combustible flowers.
Since obtaining Health Canada’s
approval for its independent cannabis research and development lab, EnWave has
used this opportunity to expand research and to develop programs such as
Terpene Max™. With a fully commissioned R&D facility, the Company is now
available to perform cannabis testing and demonstrations for prospective
partners evaluating the use of REV™ technology to process cannabis.
With EnWave now able to conduct
on-site trials with various cannabis strains, the perceived technology risk is reduced
for prospective licensees.
REV™ drying technology provides
cannabis producers with a rapid and gentle drying solution that produces
premium cannabis products for both extraction and combustion while
significantly reducing processing delays. The REV™ process can also reduce the
bioburden in the product and lowers the risk of crop loss due to microbes and
other quality issues. REV™ has been embraced by several licensed cannabis and
hemp producers in Canada, Switzerland, New Zealand, Australia, and the United
States of America.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Investors can trade these stocks
and other ideas on our site using our list of top stock trading
apps including Robinhood, Acorn,
Stash and others.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes, Spotify,
Google Play Music, Stitcher, Spreaker,
YouTube via Spreaker, iHeartradio
and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
No comments:
Post a Comment